San Francisco, Ca., USA - October 15, 2009, San Francisco, Ca., USA - Five Prime Therapeutics, Inc. announced that Aron Knickerbocker has joined the company as vice president business development, Marc Belsky as vice president finance and Lauretta Cesario as vice president human resources.
Article continues below
Aron Knickerbocker brings substantial experience in business development, licensing and corporate development. Mr. Knickerbocker joins FivePrime from Genentech, Inc. where he most recently served as senior director, business development, leading Genentech's oncology business development team and responsible for evaluating and negotiating strategic alliances.
Mr. Knickerbocker has worked previously with Alza Corporation, where he managed licensing transactions as their director of commercial development, and held sales, market research, marketing, and corporate development positions at Amgen, Inc. He began his career in the biopharmaceutical industry in research as a scientist at Bristol-Myers Squibb. Mr. Knickerbocker received his B.A. degree in biology from Washington University in St. Louis, and his M.B.A. degree from the University of Michigan.
Marc Belsky brings extensive experience in finance, accounting, treasury and taxation. He joins FivePrime after serving as vice president and chief accounting officer for Cell Genesys, Inc.
Previously, Mr. Belsky was the chief financial officer at Active Aero Group and DataWave Systems, Inc. and held senior finance and banking positions at Michigan National Corporation. Mr. Belsky started his career as an auditor with Coopers & Lybrand, is a certified public accountant, a certified treasury professional, and received an M.B.A. from the University of Michigan and a B.S. in accounting from Wayne State University. At FivePrime, he will lead the company's finance and accounting group.
Lauretta Cesario brings significant experience in human resources, recently as vice president human resources with Affymetrix, Inc. where she transformed the HR function into a functionally differentiated team supported by advanced technologies. Prior to Affymetrix, she was formerly with Scios, Inc, Silicon Graphics, Inc., National Semiconductor Corporation and Syntex Corporation. ■